January 27, 2025 11:06 AM EST
R&D
Pharma

Bris­tol My­ers shares IO com­bo da­ta in col­orec­tal can­cer; Pfiz­er still wait­ing on Braftovi reg­i­men sur­vival fig­ures

Ayisha Sharma

News Reporter

Sev­er­al drug­mak­ers shared new clin­i­cal da­ta at this year’s AS­CO GI Sym­po­sium in San Fran­cis­co, and End­points News has round­ed up a hand­ful of no­table …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

One Feb­ru­ary FDA ad­comm meet­ing is de­layed, an­oth­er can­celed

The RFK ques­tion: Trump's HHS nom­i­nee splits bio­phar­ma be­fore mo­ment of truth

Semaglu­tide, tirzepatide com­pounder hit with FDA warn­ing let­ter 

No­vo Nordisk asks Third Cir­cuit to ex­pe­dite IRA case as par­tic­i­pa­tion dead­line looms

Ozem­pic la­bel ex­pand­ed to in­clude re­duced risk of wors­en­ing kid­ney dis­ease

sponsored

Why the pre­mier re­cruit­ment agency in the world is giv­ing up re­cruit­ing, and spon­sors should, too

A service from the Financial Times